Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Dose Optimization of Rociletinib for EGFR Mutated NSCLC Goldman, J. W., Wakelee, H. A., Gadgeel, S., Camidge, D. R., Solomon, B. J., Yu, H., Oxnard, G. R., Ou, S., Papadimitrakopoulou, V., Perol, M., Reckamp, K., Soria, J., Varga, A., Dziadziuszko, R., Despain, D., Matheny, S., Sequist, L. V. ELSEVIER SCIENCE INC. 2015: S318–S319
View details for Web of Science ID 000370365101174